Free Trial
NASDAQ:BHST

BioHarvest Sciences (BHST) Stock Price, News & Analysis

BioHarvest Sciences logo
$6.65 +0.21 (+3.26%)
As of 12:58 PM Eastern

About BioHarvest Sciences Stock (NASDAQ:BHST)

Key Stats

Today's Range
$6.30
$6.69
50-Day Range
$5.03
$6.75
52-Week Range
$6.30
$7.38
Volume
13,563 shs
Average Volume
18,454 shs
Market Capitalization
$109.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00
Consensus Rating
Buy

Company Overview

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.

Receive BHST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter.

BHST Stock News Headlines

The Man I Turn to In Times Like This
A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.
See More Headlines

BHST Stock Analysis - Frequently Asked Questions

BioHarvest Sciences' stock was trading at $6.18 on January 1st, 2025. Since then, BHST stock has increased by 7.6% and is now trading at $6.65.
View the best growth stocks for 2025 here
.

BioHarvest Sciences Inc. (NASDAQ:BHST) issued its quarterly earnings data on Monday, March, 31st. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.05. The business earned $7.17 million during the quarter, compared to analyst estimates of $7.24 million.
Read the conference call transcript
.

Top institutional shareholders of BioHarvest Sciences include Magnus Financial Group LLC (0.44%).

Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
3/31/2025
Today
5/01/2025
Next Earnings (Estimated)
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BHST
Previous Symbol
NASDAQ:BHST
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.00
High Stock Price Target
$14.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+95.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-12,560,000.00
Pretax Margin
-76.65%

Debt

Sales & Book Value

Annual Sales
$25.19 million
Price / Cash Flow
N/A
Book Value
($1.08) per share
Price / Book
-6.16

Miscellaneous

Free Float
N/A
Market Cap
$109.23 million
Optionable
N/A
Beta
0.84
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:BHST) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners